RefillPill.com - Cheap drugs and prescription medication
RefillPill.com Pharma Links Directory logo

RefillPill.com - Online Health Help
Search : Find drug site

Health Help Resources:
Drug Index
Heart Conditions
Online Drug News
  • Ranbaxy Laboratories Ltd. said on Wednesday that a U.S. appeals court has granted an injunction against its proposed launch of a generic version of Pfizer Inc.'s blood pressure drug Accupril.
    read more >>
  • The events of the past couple of months have prompted one to ask whether Ranbaxy needs more lawyers as it fights a slew of litigations in the U.S. or a team of talented scientists to develop new drugs.
    read more >>
  • BOSTON (AFX) -- A federal appeals court on Tuesday upheld an injunction preventing the launch of a generic version of Pfizer's blood-pressure drug Accupril, also known as quinapril.
    read more >>
  • NEW YORK, Nov. 22 (UPI) -- Pfizer said Tuesday that it has won its patent lawsuit against generic-drug firms Ranbaxy and Teva over quinapril. The drug, sold by Pfizer as Accupril, is used to treat high blood pressure and heart failure. The drug is made by Ranbaxy and marketed by Teva.
    read more >>
  • BOSTON (MarketWatch) -- A federal appeals court on Tuesday upheld an injunction preventing the marketing of a generic version of Pfizer's blood-pressure drug Accupril, also known as quinapril.
    read more >>
  • BOSTON (AFX) -- Pharmaceutical stocks closed slightly higher Wednesday, prodded by upbeat developments in patent lawsuits involving Pfizer's Accupril and AstraZeneca's Nexxium.
    read more >>
  • Ranbaxy Laboratories Ltd on Wednesday said the US Court of Appeals for the Federal Circuit (CAFC) has upheld the preliminary directive granted by a district court that barred its subsidiary from marketing its antihypertensive tablets in that country.
    read more >>
  • BOSTON (AFX) -- Pharmaceutical stocks inched into positive territory Wednesday, prodded largely by positive developments in patent lawsuits involving Pfizer's Accupril and AstraZeneca's Nexxium.
    read more >>
  • Regulations / Law Ranbaxy Laboratories Ltd on Wednesday said the US Court of Appeals for the Federal Circuit (CAFC) has upheld the preliminary directive granted by a district court that barred its subsidiary from marketing its antihypertensive tablets in that country.
    read more >>
  • MUMBAI: Ranbaxy Laboratories Ltd on Wednesday said that the US Court of Appeals for the Federal Circuit (CAFC) has upheld the preliminary directive granted by a district court that barred its subsidiary from marketing its anti-hypertensive tablets in tha t country.
    read more >>


Sign up for FREE to the most read Newsletter on cheap drugs! We track all the drug ads out there and help you zero in on the really great deals.

Enter To Claim your Instant Coupon Code...


Enter to get an instant discount on all your pharmacy needs.

Name:  
Email:  
Privacy

Terms


ACCUPRIL

BRAND NAME: Accupril

GENERIC NAME: quinapril

DRUG CLASS AND MECHANISM:

Quinapril belongs in a class of drugs called angiotensin converting enzyme (ACE) inhibitors. ACE inhibitors are used for treating high blood pressure and heart failure and for preventing kidney failure due to hypertension and diabetes. Other drugs in this class are enalapril (Vasotec), ramipril (Altace), captopril (Capoten), fosinopril (Monopril), benazepril (Lotensin), lisinopril (Zestril, Prinivil), moexipril (Univasc) and trandolapril (Mavik). Angiotensin converting enzyme is important because it produces angiotensin II. Angiotensin II contracts the muscles of the arteries in the heart and the rest of the body, narrowing the arteries and thereby elevating blood pressure. In the kidney, the narrowing caused by angiotensin II decreases blood flow and increases the filtration pressure in the kidney. ACE inhibitors such as quinapril lower blood pressure by inhibiting the formation of angiotensin II, thereby relaxing the arterial muscles and enlarging the arteries. This increases the flow of blood and oxygen to the heart so that it can pump blood more efficiently. The enlargement of the arteries elsewhere in the body also makes it easier for the heart to pump blood. This is particularly beneficial when there is heart failure. In the kidneys this increases blood flow and reduces the filtration pressure in the kidneys. Quinapril was approved by the FDA in November, 1991.

PRESCRIPTION:

yes

GENERIC AVAILABLE:

yes

PREPARATIONS:

Tablets: 5, 10, 20 and 40 mg

STORAGE:

Store tablets and solutions at room temperature 15-30°C (59-86°F).

PRESCRIBED FOR:

Quinapril is used alone or in combination with other drugs to treat hypertension and heart failure. As with other ACE inhibitors, quinapril also is used to delay the progression of kidney failure in patients with diabetes.

DOSING:

The recommended dose for treating hypertension is 10-80 mg a day as a single dose or in two doses. The dose for heart failure is 20-40 mg a day in two divided doses. Quinapril should be taken on an empty stomach because food reduces its absorption.

DRUG INTERACTIONS:

The use of ACE inhibitors with potassium supplements, salt substitutes or diuretics (e.g., spironolactone) that increase potassium in the blood may lead to excessive potassium levels. Potassium levels should be closely monitored whenever ace inhibitors are use in combination with these drugs.

PREGNANCY:

Angiotensin converting enzyme inhibitors, including quinapril, are very harmful to the fetus and, therefore, should not be used during pregnancy.

NURSING MOTHERS:

Quinapril is secreted into breast milk. Because of the risk of harm to the infant, quinapril should be used with caution during breast feeding.

SIDE EFFECTS:

Quinapril is generally well tolerated, and side effects are usually mild and transient. A dry, persistent cough has been reported with the use of quinapril and other ACE inhibitors. Coughing resolves after discontinuing the medication. Other side effects include abdominal pain, constipation, diarrhea, rash, dizziness, fatigue, headache, loss of taste, loss of appetite, nausea, vomiting, fainting and numbness or tingling in the hands or feet. Quinapril and other ACE inhibitors may also cause kidney failure and increased levels of potassium in the blood. The most serious but very rare side effects are liver failure and angioedema (swelling of lips and throat).